精子线粒体DNA拷贝数:男性生育力与生殖成功的标志物
本综述汇总了21项流行病学、实验和临床研究,评估精子线粒体DNA拷贝数(mtDNAcn)作为男性生育力生物标志物的证据。 elevated sperm mtDNAcn与精子浓度、总数、活力和正常形态降低相关,并与精子DNA碎片率升高及妊娠可能性降低相关,但夫妻层面生殖潜力的关联不一致。
要点
- 精子mtDNAcn升高与精液质量下降及精子DNA碎片增加相关。
- mtDNAcn与夫妻妊娠可能性的关联不一致,需大样本前瞻研究验证。
- 标准化检测方案和临床阈值是推动mtDNAcn临床转化的关键。
核心结论
- 精子mtDNAcn是具生物学信息且临床相关的男性生殖健康指标,可能补充或增强传统精液分析。
研究设计与样本
- 综述汇总21项流行病学、实验和临床研究,检索PubMed、Web of Science和Scopus截至2026年4月1日。
主要发现
- 较高mtDNAcn与较低精子浓度、总数、活力和正常形态相关,并与较高精子DNA碎片和染色质异常相关。
- 较高mtDNAcn与妊娠可能性降低和胚胎质量较差相关。
- 新兴证据提示mtDNAcn与核DNA甲基化模式改变相关,支持线粒体-核交互作用。
临床怎么用
- 精子mtDNAcn可作为男性生育力评估的辅助标志物,但临床阈值尚未确立。
- 需建立跨精子组分和实验室平台的标准化测量方案以促进临床转化。
局限性
- mtDNAcn与夫妻层面生殖潜力的关联不一致,需大样本前瞻研究定义临床有意义阈值。
- 标准化测量协议尚未建立,影响跨研究可比性和临床转化。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Sperm mitochondrial DNA copy number (mtDNAcn) has emerged as a promising biomarker of sperm health, providing molecular insight beyond what is captured by standard semen analysis. Elevated sperm mtDNAcn has been consistently associated with lower sperm motility, concentration, and morphology, as well as prolonged time-to-pregnancy in natural conception and reduced fertilization potential in ART. OBJECTIVE AND RATIONALE: This review summarizes current evidence on the biological underpinnings of sperm mtDNAcn, including its regulation during spermatogenesis, the role of nuclear-encoded mitochondrial proteins such as TFAM (mitochondrial transcription factor A), and its potential epigenetic modulation through sperm DNA methylation. We evaluate general population and clinic-based studies linking sperm mtDNAcn to semen quality, couple fecundity, and early embryo development, while highlighting methodological considerations such as quantification techniques and somatic cell contamination. SEARCH METHODS: A literature search was conducted to identify human studies evaluating sperm mtDNAcn in relation to male fertility, semen quality, reproductive outcomes, and embryology outcomes, as well as experimental models investigating the underlying biological mechanisms of mtDNA regulation during spermatogenesis via TFAM up to 1 April 2026. Searches were performed in PubMed, Web of Science, and Scopus using combinations of keywords and Medical Subject Headings (MeSH), including sperm mitochondrial DNA copy number, mtDNAcn, male infertility, pregnancy outcomes, ART outcomes, semen quality, sperm epigenetics, TFAM, mitochondrial transcription factor A, and sperm mtDNA regulation. Reference lists of relevant reviews and primary articles were manually screened to identify additional studies. Eligible studies included observational epidemiologic studies, clinical cohort studies, and experimental investigations that quantified sperm mtDNAcn and examined associations with semen parameters, fertility outcomes, or sperm epigenetics. No restrictions were placed on geographic location, while only articles published in English were considered. OUTCOMES: Across 21 epidemiologic, experimental, and clinical studies, elevated sperm mtDNAcn has been consistently associated with reduced sperm quality and inconsistently associated with diminished couple-level reproductive potential. Higher mtDNAcn is associated with lower sperm concentration, total sperm count, motility, and normal morphology, as well as higher sperm DNA fragmentation and chromatin abnormalities. It has also been linked to reduced likelihood of pregnancy and poorer embryo quality. Emerging evidence indicates associations between sperm mtDNAcn and altered nuclear DNA methylation patterns, supporting a role for mitochondrial-nuclear crosstalk. Collectively, these findings position sperm mtDNAcn as a biologically informative and clinically relevant indicator of male reproductive health that may complement, or potentially enhance, traditional semen analysis in both research and clinical settings. WIDER IMPLICATIONS: Sperm mtDNAcn holds promise as a biomarker for male fertility assessment, yet its full clinical potential has not been yet to be realized. Establishing standardized measurement protocols across sperm fractions and laboratory platforms will be essential for enabling cross-study comparability and facilitating clinical translation. Large prospective studies are needed to define clinically meaningful thresholds and better characterize the relationship between mtDNAcn alterations and spermatogenic impairment. Intervention strategies targeting mtDNA biogenesis and depletion, including antioxidant strategies and mitochondria-directed pharmacotherapy, warrant further investigation in the context of male fertility and fecundity. Collectively, sperm mtDNAcn may serve as an adjunctive marker in the assessment of male reproductive health and may inform future precision medicine approaches. REGISTRATION NUMBER: N/A.
引用
- Sawant S, Mann JM, Pilsner JR, et al. Sperm mitochondrial DNA copy number: a marker of male fertility and reproductive success. Hum Reprod Update. 2026. PMID: 42172631. doi:10.1093/humupd/dmag013
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。